Company profile: Euroimmun
1.1 - Company Overview
Company description
- Provider of medical laboratory diagnostics, designing, manufacturing, and selling disease detection test systems, with software and automation for test execution and evaluation. Products are used to diagnose autoimmune and infectious diseases; offerings include EURORealTime APOE, EURORealTime RSV A/B, SwiftX-traction, Chemiluminescence Immunoassays (ChLIA), and training via EUROIMMUN Academy.
Products and services
- Chemiluminescence Immunoassays (ChLIA): Chemiluminescent immunoassay-based assays detect Alzheimer biomarkers and deliver analytical and clinical data, enabling reliable biomarker quantification for Alzheimer-related evaluation
- EURORealTime APOE: Genotyping-based test identifies the APOE ε4 allele to assess risk of side effects in Alzheimer’s therapy through allele-specific detection
- EURORealTime RSV A/B: Real-time PCR-based assay directly detects RSV A and B, aiding cold-season preparedness through precise, real-time amplification and detection of RSV targets
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Euroimmun
Epiva
HQ: United States
Website
- Description: Provider of immuno-microbiome therapeutics, developing immunobiotic therapeutics through a platform from Flagship VentureLabs, the innovation foundry of Flagship Ventures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Epiva company profile →
Fumapharm
HQ: Switzerland
Website
- Description: Provider of pharmaceuticals as a privately held company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fumapharm company profile →
Allenex
HQ: Sweden
Website
- Description: Provider of products for blood stem cell and organ transplantation, including genomic HLA typing kits used prior to hematopoietic stem cell/bone marrow and organ transplants to match donors; develops, manufactures, markets, and sells worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Allenex company profile →
Kadmon
HQ: United States
Website
- Description: Provider of biopharmaceutical products and services for the treatment and management of hepatitis C, including Ribasphere RibaPak (ribavirin, USP) tablets that reduce pill burden and deliver treatment biologically equivalent to other ribavirin medications, and INFERGEN (interferon).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kadmon company profile →
Aera Therapeutics
HQ: United States
Website
- Description: Provider of a proprietary protein nanoparticle (PNP) delivery platform based on human proteins to deliver genetic medicines across modalities and therapeutic areas, and a therapeutic enzyme platform with novel, compact, programmable gene-editing enzymes to overcome packaging and delivery challenges in gene therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aera Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Euroimmun
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Euroimmun
2.2 - Growth funds investing in similar companies to Euroimmun
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Euroimmun
4.2 - Public trading comparable groups for Euroimmun
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →